Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models
- 31 May 2010
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 86 (2), 121-127
- https://doi.org/10.1016/j.antiviral.2009.10.015
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infectionsAntiviral Research, 2009
- Prophylaxis with cationic liposome–DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifsAntiviral Research, 2009
- Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106Antimicrobial Agents and Chemotherapy, 2009
- EFFICACY OF POST-EXPOSURE TREATMENT OF YELLOW FEVER WITH RIBAVIRIN IN A HAMSTER MODEL OF THE DISEASEThe American Journal of Tropical Medicine and Hygiene, 2004
- INDUCTION OF SEVERE DISEASE IN HAMSTERS BY TWO SANDFLY FEVER GROUP VIRUSES, PUNTA TORO AND GABEK FOREST (PHLEBOVIRUS, BUNYAVIRIDAE), SIMILAR TO THAT CAUSED BY RIFT VALLEY FEVER VIRUSThe American Journal of Tropical Medicine and Hygiene, 2003
- Hemorrhagic Fever Viruses as Biological WeaponsJama-Journal Of The American Medical Association, 2002
- In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705Antimicrobial Agents and Chemotherapy, 2002
- Experimental Yellow Fever Virus Infection in the Golden Hamster(Mesocricetus auratus).II. PathologyThe Journal of Infectious Diseases, 2001
- Experimental Yellow Fever Virus Infection in the Golden Hamster(Mesocricetus auratus).I. Virologic, Biochemical, and Immunologic StudiesThe Journal of Infectious Diseases, 2001
- Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activatorAntiviral Research, 1986